← Eichor
Study identifier: NCT07248956 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma

Condition: Hypopharyngeal Carcinoma  ·  Sponsor: Eye & ENT Hospital of Fudan University

PhasePhase 2
Planned participants116
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

This is a multi-center, randomized controlled, prospective clinical study.

This description comes directly from the study's public registry record.

Talk to the study team

Chiyao Hsueh  ·  021-64377134  ·  hsuehchiyao@gmail.com

Always discuss trial participation with your own doctor first.

Locations (7)

Harbin Medical University Cancer HospitalHarbin, Heilongjiang, ChinaNot Yet Recruiting
Shandong Provincial ENT HospitalJinan, Shandong, ChinaNot Yet Recruiting
Beijing Tongren Hospital, Capital Medical UniversityBeijing, ChinaNot Yet Recruiting
Cancer Hospital Chinese Academy of Medical SciencesBeijing, ChinaNot Yet Recruiting
Eye & ENT Hospital, Fudan UniversityShanghai, ChinaRecruiting
Zhongshan Hospital of Fudan UniversityShanghai, ChinaNot Yet Recruiting
Tianjin Medical University Cancer Institute & HospitalTianjin, ChinaNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07248956